Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder, which is commonly related to reduced insulin responsiveness and altered appetite-related hormones. In this study, we have evaluated how combined metformin and sulfonylurea therapy affects glycemic indicators and appetite hormones, with special focus on hormone ratios. Sixty participants were involved in the study: 30 diabetic patients receiving combined metformin-sulfonylurea therapy and 30 conditionally healthy individuals serving as controls. Fasting blood samples were collected to assess indicators of glycemic control, lipid profiles, and hormone levels using standard biochemical assays and ELISA. The patient group showed clear increases in fasting glucose, HbA1c, insulin, insulin resistance indices, lipid profile measurements, and leptin levels, whereas the levels of HDL, ghrelin, and adiponectin were markedly decreased compared with the control group (p < 0.001). The results of the study show that T2DM patients continue to have both insulin resistance and poor blood glucose control despite combined metformin-sulfonylurea therapy. Alterations in appetite hormones also reflect underlying metabolic dysregulation, and hormonal ratios, especially the leptin/adiponectin ratio, are more accurate indicators of this imbalance than individual hormone measurements.
Hussein S.M., Zaidan N.K. (2026) Evaluation of insulin, leptin, ghrelin, and adiponectin levels in type 2 diabetic patients receiving combined metformin-sulfonylurea therapy. Biomeditsinskaya Khimiya, 72(3), 230-235.
Hussein S.M. et al. Evaluation of insulin, leptin, ghrelin, and adiponectin levels in type 2 diabetic patients receiving combined metformin-sulfonylurea therapy // Biomeditsinskaya Khimiya. - 2026. - V. 72. -N 3. - P. 230-235.
Hussein S.M. et al., "Evaluation of insulin, leptin, ghrelin, and adiponectin levels in type 2 diabetic patients receiving combined metformin-sulfonylurea therapy." Biomeditsinskaya Khimiya 72.3 (2026): 230-235.
Hussein, S. M., Zaidan, N. K. (2026). Evaluation of insulin, leptin, ghrelin, and adiponectin levels in type 2 diabetic patients receiving combined metformin-sulfonylurea therapy. Biomeditsinskaya Khimiya, 72(3), 230-235.
References
Zaidan N.K., Saifullah P.H. (2020) Effects of sulfonylureas treatment on apoptosis, total superoxide dismutase activity and some biochemical parameters in type 2 diabetic patients. Indian J. Forensic Med. Toxicol., 14(2), 1050–1055. CrossRef Scholar google search
Antar S.A., Ashour N.A., Sharaky M., Khattab M., Ashour N.A., Zaid R.T., Roh E.J., Elkamhawy A., Al-Karmalawy A.A. (2023) Diabetes mellitus: classification, mediators, and complications; a gate to identify potential targets for the development of new effective treatments. Biomed. Pharmacother., 168, 115734. CrossRef Scholar google search
Zerihun E., Abera F., Kune G., Girma F., Tesgera M., Robi M. (2024) Undiagnosed status and associated factors of diabetes mellitus among adults living in eastern Ethiopia: unmasking a silent killer of prevalence of diabetes mellitus. Clin. Epidemiol. Glob. Health, 25, 101483. CrossRef Scholar google search
Mohammed W.M., Zaidan N.K., Al-Hadithe H.A.K. (2024) Evaluation of some inflammatory markers enzymes in T2DM patients. Res. J. Biotechnol., 19(8), 31–34. CrossRef Scholar google search
Le T.K.C., Dao X.D., Nguyen D.V., Luu D.H., Bui T.M.H., Le T.H., Nguyen H.T., Le T.N., Hosaka T., Nguyen T.T.T. (2023) Insulin signaling and its application. Front. Endocrinol., 14, 1226655. CrossRef Scholar google search
Zaidan N.K., Saifullah P.H. (2020) Metformin and metformin plus insulin combination effect on some apoptosis factors and biochemical parameters in type 2 diabetic patients. Biochem. Cell. Arch., 20(1), 1653–1659. CrossRef Scholar google search
Sun X., Liu B., Yuan Y., Rong Y., Pang R., Li Q. (2025) Neural and hormonal mechanisms of appetite regulation during eating. Front. Nutr., 12, 1484827. CrossRef Scholar google search
Wang J.L., Xiao Y., Li M.L., Chen G.L., Cui M.H., Liu J.L. (2025) Research progress on leptin in metabolic dysfunctionassociated fatty liver disease. J. Clin. Transl. Hepatol., 13(11), 964–975. CrossRef Scholar google search
Liu Z., Xiao T., Liu H. (2023) Leptin signaling and its central role in energy homeostasis. Front. Neurosci., 17, 1238528. CrossRef Scholar google search
Hristov M. (2025) Leptin signaling in the hypothalamus: cellular insights and therapeutic perspectives in obesity. Endocrines, 6(3), 42. CrossRef Scholar google search
Jiao Z.-T., Luo Q. (2022) Molecular mechanisms and health benefits of ghrelin: a narrative review. Nutrients, 14(19), 4191. CrossRef Scholar google search
Liu J., Jing C., Guo Y., Shang Z., Zhang B., Zhou X., Zhang J., Lian G., Tian F., Li L., Chen Y. (2025) The central signaling pathways related to metabolism-regulating hormones of the gut-brain axis: a review. J. Transl. Med., 23, 648. CrossRef Scholar google search
Baldelli S., Aiello G., Mansilla di Martino E., Campaci D., Muthanna F.M., Lombardo M. (2024) The role of adipose tissue and nutrition in the regulation of adiponectin. Nutrients, 16(15), 2436. CrossRef Scholar google search
Razi O., Zamani N., de Moraes C., Laher I., Hadjicharalambous M. (2025) Exercise suppresses appetite in obesity: a biochemical, metabolic, and molecular approach. Appl. Sci., 15(11), 6191. CrossRef Scholar google search
Naja K., Anwardeen N., Bashraheel S.S., Elrayess M.A. (2024) Pharmacometabolomics of sulfonylureas in patients with type 2 diabetes: a cross-sectional study. J. Pharm. Pharm. Sci., 27, 13305. CrossRef Scholar google search
Beyer E.M. Jr., Duffy M.J., Hay J.V., Schlueter D.D. (2024) Sulfonylureas. In: Herbicides: Chemistry, Degradation, and Mode of Action (Kearney P.C., Kaufman D.D., eds.), vol. 3. CRC Press, Boca Raton, pp. 117–189. CrossRef Scholar google search
Lazzaroni E., Nasr M.B., Loretelli C., Pastore I., Plebani L., Lunati M.E., Vallone L., Bolla A.M., Rossi A., Montefusco L., Ippolito E., Berra C., d'Addio F., Zuccotti G.V., Fiorina P. (2021) Anti-diabetic drugs and weight loss in patients with type 2 diabetes. Pharmacol. Res., 171, 105782. CrossRef Scholar google search
AlJabr Q., Alalawi M., Aldhneen B., Gharash A.A., Aldabbab M., Aldabbab H., Bu-Khamseen A., Alkattan A., Sayafi A.A. (2024) Association of BMI and incidence of type 2 diabetes in Saudi population. Health Sci. Rep., 7(3), e1951. CrossRef Scholar google search
Mohajan D., Mohajan H.K. (2024) Sulfonylureas: a widely used oral anti-hyperglycaemic medication for type 2 diabetes management. J. Innov. Med. Res., 3(1), 14–19. CrossRef Scholar google search
Garutti M., Sirico M., Noto C., Foffano L., Hopkins M., Puglisi F. (2025) Hallmarks of appetite: a comprehensive review of hunger, appetite, satiation, and satiety. Curr. Obes. Rep., 14, 12. CrossRef Scholar google search
Khadka B., Pandey S., Kafle D. (2023) Dyslipidemia among patients with type 2 diabetes mellitus visiting a tertiary care centre. J. Nepal Med.Assoc., 61(266), 758–761. CrossRef Scholar google search
Vijayashankar U., Ramashetty R., Rajeshekara M., Vishwanath N., Yadav A.K., Prashant A., Lokeshwaraiah R. (2024) Leptin and ghrelin dynamics: unraveling their influence on food intake, energy balance, and the pathophysiology of type 2 diabetes mellitus. J. Diabetes Metab. Disord., 23(1), 427–440. CrossRef Scholar google search
Rausch J., Horne K.E., Marquez L. (2025) The effects of adipose tissue dysregulation on type 2 diabetes mellitus. Biomedicines, 13(7), 1770. CrossRef Scholar google search
Agostinis-Sobrinho C., Vicente S.E.C.F., Norkiene S., Rauckienė-Michaelsson A., Kievisienė J., Dubey V.P., Razbadauskas A., Lopes L., Santos R. (2022) Is the leptin/adiponectin ratio a better diagnostic biomarker for insulin resistance than leptin or adiponectin alone in adolescents? Children (Basel), 9(8), 1193. CrossRef Scholar google search
Gupta A., Gupta P., Singh A.K., Gupta V. (2023) Association of adipokines with insulin resistance and metabolic syndrome including obesity and diabetes. GHM Open, 3(1), 7–19. CrossRef Scholar google search
